Mark J Gergen Poseida Therapeutics, Inc. (PSTX) insider trading activity

PSTX Quotes by TradingView

Mark J Gergen is Executive Chairman of Poseida Therapeutics, Inc.. Currently has a direct ownership of 651,291 shares of PSTX, which is worth approximately $1.76 Million. The most recent transaction as insider was on Mar 01, 2024, when has been sold 34,157 shares (Common Stock) at a price of $4.13 per share, resulting in proceeds of $141,068. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 651K
0% 3M change
8.26% 12M change
Total Value Held $1.76 Million

Mark J Gergen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2024
SELL
Payment of exercise price or tax liability
$141,068 $4.13 p/Share
34,157 Reduced 4.98%
651,291 Common Stock
Feb 01 2024
SELL
Payment of exercise price or tax liability
$160,822 $3.41 p/Share
47,162 Reduced 6.44%
685,448 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
125,000 Added 14.58%
732,610 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
269,586 Added 30.94%
601,610 Common Stock
Feb 01 2023
SELL
Payment of exercise price or tax liability
$222,733 $7.0 p/Share
31,819 Reduced 8.79%
330,314 Common Stock
Feb 01 2022
BUY
Grant, award, or other acquisition
-
357,200 Added 50.0%
357,200 Common Stock
MJG

Mark J Gergen

Executive Chairman
San Diego, CA

Track Institutional and Insider Activities on PSTX

Follow Poseida Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PSTX shares.

Notify only if

Insider Trading

Get notified when an Poseida Therapeutics, Inc. insider buys or sells PSTX shares.

Notify only if

News

Receive news related to Poseida Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PSTX